183 related articles for article (PubMed ID: 9700940)
1. Effect of a platelet-activating factor antagonist on pancreatitis-associated gut barrier dysfunction in rats.
Andersson R; Wang X; Sun Z; Deng X; Soltesz V; Ihse I
Pancreas; 1998 Aug; 17(2):107-19. PubMed ID: 9700940
[TBL] [Abstract][Full Text] [Related]
2. Severity of pancreatitis-associated gut barrier dysfunction is reduced following treatment with the PAF inhibitor lexipafant.
Leveau P; Wang X; Sun Z; Börjesson A; Andersson E; Andersson R
Biochem Pharmacol; 2005 May; 69(9):1325-31. PubMed ID: 15826603
[TBL] [Abstract][Full Text] [Related]
3. Beneficial effects of lexipafant, a PAF antagonist on gut barrier dysfunction caused by intestinal ischemia and reperfusion in rats.
Sun Z; Wang X; Deng X; Lasson A; Soltesz V; Börjesson A; Andersson R
Dig Surg; 2000; 17(1):57-65. PubMed ID: 10720833
[TBL] [Abstract][Full Text] [Related]
4. Treatment with lexipafant ameliorates the severity of pancreatic microvascular endothelial barrier dysfunction in rats with acute hemorrhagic pancreatitis.
Wang X; Sun Z; Börjesson A; Haraldsen P; Aldman M; Deng X; Leveau P; Andersson R
Int J Pancreatol; 1999 Feb; 25(1):45-52. PubMed ID: 10211421
[TBL] [Abstract][Full Text] [Related]
5. Effective treatment of gut barrier dysfunction using an antioxidant, a PAF inhibitor, and monoclonal antibodies against the adhesion molecule PECAM-1.
Sun Z; Olanders K; Lasson A; Dib M; Annborn M; Andersson K; Wang X; Andersson R
J Surg Res; 2002 Jun; 105(2):220-33. PubMed ID: 12121711
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of platelet-activating factor, intercellular adhesion molecule 1 and platelet endothelial cell adhesion molecule 1 reduces experimental pancreatitis-associated gut endothelial barrier dysfunction.
Wang X; Sun Z; Börjesson A; Andersson R
Br J Surg; 1999 Mar; 86(3):411-6. PubMed ID: 10201790
[TBL] [Abstract][Full Text] [Related]
7. Effects of inhibition of PAF, ICAM-1 and PECAM-1 on gut barrier failure caused by intestinal ischemia and reperfusion.
Sun Z; Wang X; Lasson A; Böjesson A; Annborn M; Andersson R
Scand J Gastroenterol; 2001 Jan; 36(1):55-65. PubMed ID: 11218240
[TBL] [Abstract][Full Text] [Related]
8. Effect of platelet-activating factor antagonists (BN-52021, WEB-2170, and BB-882) on bacterial translocation in acute pancreatitis.
de Souza LJ; Sampietre SN; Assis RS; Knowles CH; Leite KR; Jancar S; Monteiro Cunha JE; Machado MC
J Gastrointest Surg; 2001; 5(4):364-70. PubMed ID: 11985976
[TBL] [Abstract][Full Text] [Related]
9. Platelet-activating factor.
Kingsnorth AN
Scand J Gastroenterol Suppl; 1996; 219():28-31. PubMed ID: 8865468
[TBL] [Abstract][Full Text] [Related]
10. Early treatment with lexipafant, a platelet-activating factor-receptor antagonist, is not sufficient to prevent pulmonary endothelial damage after intestinal ischaemia and reperfusion in rats.
Börjesson A; Wang X; Sun Z; Inghammar M; Truedsson L; Andersson R
Dig Liver Dis; 2002 Mar; 34(3):190-6. PubMed ID: 11990391
[TBL] [Abstract][Full Text] [Related]
11. Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis.
Johnson CD; Kingsnorth AN; Imrie CW; McMahon MJ; Neoptolemos JP; McKay C; Toh SK; Skaife P; Leeder PC; Wilson P; Larvin M; Curtis LD
Gut; 2001 Jan; 48(1):62-9. PubMed ID: 11115824
[TBL] [Abstract][Full Text] [Related]
12. The effect of lexipafant on bacterial translocation in acute necrotizing pancreatitis in rats.
Liu Q; Djuricin G; Rossi H; Bewsey K; Nathan C; Gattuso P; Weinstein RA; Prinz RA
Am Surg; 1999 Jul; 65(7):611-6; discussion 617. PubMed ID: 10399968
[TBL] [Abstract][Full Text] [Related]
13. Therapy for microcirculatory disorders in severe acute pancreatitis: effectiveness of platelet-activating factor receptor blockade vs. endothelin receptor blockade.
Foitzik T; Hotz HG; Eibl G; Hotz B; Kirchengast M; Buhr HJ
J Gastrointest Surg; 1999; 3(3):244-51. PubMed ID: 10481117
[TBL] [Abstract][Full Text] [Related]
14. Multimodal management - of value in fulminant acute pancreatitis?
Haraldsen P; Sun ZW; Börjesson A; Olanders K; Lasson A; Andersson R
Pancreatology; 2003; 3(1):14-25. PubMed ID: 12649560
[TBL] [Abstract][Full Text] [Related]
15. Lung injury in the microembolic model of acute pancreatitis and amelioration by lexipafant (BB-882), a platelet-activating factor antagonist.
Galloway SW; Kingsnorth AN
Pancreas; 1996 Aug; 13(2):140-6. PubMed ID: 8829181
[TBL] [Abstract][Full Text] [Related]
16. The use of lexipafant in the treatment of acute pancreatitis.
McKay C; Curran FJ; Sharples CE; Young CA; Baxter JN; Imrie CW
Adv Exp Med Biol; 1996; 416():365-70. PubMed ID: 9131175
[TBL] [Abstract][Full Text] [Related]
17. Effects of platelet activating factor antagonist (BN50739) on gut mucosal injury in acute severe pancreatitis in pigs.
Zhu W; Li J; Tu W; Li N
Chin Med J (Engl); 2000 Aug; 113(8):756-8. PubMed ID: 11776064
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of N-acetyl-L-cysteine and platelet activating factor inhibition are not linked to intercellular adhesion molecule-1 expression after intestinal ischemia and reperfusion injury in rats.
Olanders K; Börjesson A; Sun ZW; Andersson R
Scand J Gastroenterol; 2003 Jun; 38(6):618-25. PubMed ID: 12825870
[TBL] [Abstract][Full Text] [Related]
19. Platelet activating factor antagonism reduces the systemic inflammatory response in a murine model of acute pancreatitis.
Lane JS; Todd KE; Gloor B; Chandler CF; Kau AW; Ashley SW; Reber HA; McFadden DW
J Surg Res; 2001 Aug; 99(2):365-70. PubMed ID: 11469912
[TBL] [Abstract][Full Text] [Related]
20. Roles of platelet-activating factor, interleukin-1beta and interleukin-6 in intestinal barrier dysfunction induced by mesenteric arterial ischemia and reperfusion.
Sun Z; Wang X; Lasson A; Börjesson A; Leveau P; Haraldsen P; Andersson R
J Surg Res; 1999 Nov; 87(1):90-100. PubMed ID: 10527709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
